10Barsuk JH, Cohen ER, Feinglass J, et al. Use of simulation - basededucation to reduce catheter related bloodstream infec tions[J]. Arch Intern Med,2009,169(15)=1420- 1423.
4Ramritu P, Halton K,Collignon P,et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units[J]. Am J Infect Control, 2008,36(2) : 104-117.
5Harter C, Salwender HJ, Bach A, et al. Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospec tive comparison of silver-coated and uncoated catheters[J]. Cancer,2002,94(1) ;245- 251.
6Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a corn parison between two different types of central venous catheters[J]. J Hosp Infect,2002,50(3):202-206.
7Hanna H, Benjamin R, Chatzinikolaou I, et al. Long term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients; a prospective randomized clinical trial[J]. J ClinOncol,2004,22(15):3163- 3171.
8Ostendorf T, Meinhold A, Harter C,et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients: a double blind, randomised, prospective, controlled trial[J]. Support Care Cancer, 2005,13(12):993- 1000.
9Jaeger K, Zenz S, Juttner B, et al. Reduction of catheter related infections in neutropenic patients; a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter[J]. Ann Hematol, 2005, 84(4) :258-262.
10Rijnders BJ, Van Wijngaerden E, Peetermans WE. Cathetertip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence [J]. Clin Infect Dis, 2002,35(9):1053-1058.
